Holdings A/S Novo - Jun 21, 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: 10%+ Owner
Signature: /s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
Stock symbol: VERV
Transactions as of: Jun 21, 2021
Transactions value $: $6,650,000
Form type: 4
Date filed: 6/22/2021, 05:17 PM
Previous filing: Jun 17, 2021
Next filing: Jun 23, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERV	COMMON STOCK	Conversion of derivative security		+443K			443K	Jun 21, 2021	Direct	F1
transaction	VERV	COMMON STOCK	Purchase	$6.65M	+350K	+78.96%	$19.00	793K	Jun 21, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERV	SERIES B CONVERTIBLE PREFERRED STOCK	Conversion of derivative security		-443K	-100%		0	Jun 21, 2021	COMMON STOCK	443K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Holdings A/S Novo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Each share of Series B Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date.
F2	Represents a purchase from the underwriters in the Issuer's initial public offering.